FDA plans to limit COVID vaccine to only high-risk people
Digest more
Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate vaccines and public health systems brace for another season of jabs and logistics.
The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months and older.
A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.
The US Food and Drug Administration is changing how it approves COVID-19 vaccines for Americans. What does that mean for people wanting to get vaccinations in Australia?
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of ...
Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into universal vaccines. After years of underfunding, experts say this backing is long overdue – especially following the COVID pandemic, which temporarily shifted focus to emergency vaccine production.